TAFINLAR (dabrafenib mesilate)
has been listed on the PBS for the
treatment of unresectable stage III
melanoma or stage IV metastatic
melanoma in patients with BRAF
V600 mutation, which is a genetic
change enabling tumour growth.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Dec 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Dec 13
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.